Page 146 - அவசரம் பல்கலைக்கழகம் மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
COVID-19 in Illinois updates: Here s what s happening this weekend
chicagotribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chicagotribune.com Daily Mail and Mail on Sunday newspapers.
US Coronavirus: FDA likely to authorize emergency use for coronavirus vaccine by Saturday morning, CDC doctor says
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Pfizer/BioNTech s vaccine passes another step as FDA issues emergency use authorization
eastidahonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastidahonews.com Daily Mail and Mail on Sunday newspapers.
Pfizer/BioNTech s vaccine passes another step as US FDA issues emergency use authorization
By
Jason Hanna, Christina Maxouris and Naomi Thomas, CNN
Published Dec 12, 2020 11:15:53 AM
enablePagination: false
endIndex:
(CNN) With the US Food and Drug Administration issuing an emergency use authorization for the first US coronavirus vaccine Friday night, state and federal officials are making plans to give people their first shots and convince people who are hesitant to get inoculated.
Operation Warp Speed Chief Adviser Moncef Slaoui urged Americans on Friday to look at the numbers that show the efficacy of Pfizer and BioNTech s vaccine. We have to go out there and engage with all of the leadership at all levels in our communities to help explain the features with of the vaccine, its performance, and hopefully engage with people and convince them, Slaoui said. Frankly, we couldn t do it effectively before because we couldn t be very specific.
E-Mail
BUFFALO, N.Y. - A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics took a major step toward becoming a first-in-class treatment for Fragile X Syndrome, a leading genetic cause of autism.
The drug, BPN14770, achieved positive topline results in a phase 2 clinical study. The innovative treatment improved cognitive function in adult male patients with Fragile X Syndrome.
Fragile X Syndrome - a genetic disorder for which there is no cure - is the most commonly known cause of inherited intellectual disability, according to the Centers for Disease Control and Prevention. We are very excited about the results of this study, said Mark Gurney, PhD, founder and chief executive officer of Tetra Therapeutics. In addition to being safe and well tolerated, treatment with BPN14770 led to significant cognitive improvement, specifically in the language domains, and we also saw a clinically meaningful benefit in overall daily